Diagnostic Ultrasound Market Size & Growth Forecast 2027–2036, By Segments (Portability, Technology, End-use, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape

Market Size and Growth Outlook

Diagnostic Ultrasound Market size was estimated at USD 8.63 Billion in 2026 and is projected to grow at 5.08% CAGR from 2027 to 2036, attaining USD 14.16 Billion by 2036. The industry revenue for 2027 is assessed at USD 9 Billion.

• Base Year Value (2026): USD 8.63 Billion
• CAGR (2027-2036): 5.08%
• Forecast Year Value (2036): USD 14.16 Billion
• Historical Data Period: 2022-2026
• Largest Region: North America
• Forecast Period: 2027-2036

Diagnostic Ultrasound Market Intelligence Snapshot:

• Regional Market Dynamics:

  • North America held 36.5% in 2025, driven by advanced healthcare infrastructure, high diagnostic imaging utilization, established reimbursement, and adoption of sophisticated ultrasound systems.
  • Asia Pacific is growing fastest through expanding healthcare infrastructure, higher diagnostic access, rising healthcare expenditure, and wider availability of portable, cost-efficient ultrasound systems.

• Segment Momentum:

  • Trolley systems accounted for 65.47% of the market in 2025, supported by widespread hospital use, advanced imaging capabilities, compatibility with multiple transducers, and efficiency in performing complex diagnostic examinations.
  • Maternity centers are the fastest-growing end-use segment as demand for prenatal monitoring, early fetal assessment, and specialized pregnancy care increases, encouraging wider adoption of advanced ultrasound technologies.

• Market Expansion Drivers:

  • Rising chronic disease prevalence increasing global diagnostic imaging demand
  • Aging population and rising birth rates expanding ultrasound utilization globally
  • Expansion of portable point-of-care ultrasound in ambulatory and emergency care

• Leading Market Participants:

  Key companies in the diagnostic ultrasound market include GE HealthCare (United States), Siemens Healthineers AG (Germany), Koninklijke Philips N.V. (Netherlands), Canon Medical Systems Corporation (Japan), Samsung Medison Co., Ltd. (South Korea), Fujifilm Holdings Corporation (Japan), Mindray Medical International Limited (China), Esaote S.p.A. (Italy), Hologic, Inc. (United States), Butterfly Network, Inc. (United States)

Unlock Complete Insights

Global Market Forecast Snapshot:

• Market Outlook:

  • 2026 Market Size: USD 8.63 Billion
  • 2027 Estimated Market Size: USD 9 Billion
  • Projected Market Size: USD 14.16 Billion by 2036
  • Growth Forecasts: 5.08% CAGR (2027-2036)

• Regional and Segment Outlook:

  • Leading Regional Market: North America
  • High-Growth Regional Hub: Asia Pacific
  • Core Revenue Segment: Trolley (Portability) | Doppler (Technology) | Hospitals (End-use) | General Imaging (Application)
  • Emerging Opportunity Segment: Compact/handheld (Portability) | 3D and 4D (Technology) | Maternity Centers (End-use) | Cardiology (Application)

Market Growth Drivers and Industry Trends

Rising chronic disease prevalence increasing global diagnostic imaging demand

The increasing burden of chronic conditions is creating a greater need for efficient and non-invasive diagnostic tools across healthcare systems. Rising chronic disease prevalence will drive the diagnostic ultrasound market growth as physicians increasingly rely on ultrasound imaging for disease assessment, monitoring, and treatment planning. Its ability to provide real-time visualization without radiation exposure makes ultrasound an important diagnostic option across multiple medical applications, supporting broader adoption in clinical environments.

Aging population and rising birth rates expanding ultrasound utilization globally

Demographic shifts are increasing healthcare requirements across both elderly care and maternal health applications. The diagnostic ultrasound market growth is supported by a growing aging population requiring continuous disease monitoring and rising birth rates that increase demand for prenatal imaging services. Healthcare providers are expanding ultrasound availability to support routine examinations, early detection, and improved management of diverse patient groups.

Expansion of portable point-of-care ultrasound in ambulatory and emergency care

The growing need for rapid diagnostic capabilities outside traditional hospital settings is accelerating the adoption of compact imaging solutions. Expansion of portable systems will propel the diagnostic ultrasound market growth as ambulatory centers, emergency departments, and remote care providers increasingly use point-of-care ultrasound for immediate clinical assessments. Portable technologies enable faster decision-making by bringing diagnostic imaging closer to patients during critical situations.

Growth Driver Assessment Framework
Growth Driver	Impact On CAGR	Regulatory Influence	Geographic Relevance	Adoption Rate	Impact Timeline
Rising chronic disease prevalence increasing global diagnostic imaging demand	2%	Moderate	North America, Europe, Asia Pacific	High	Near Term
Aging population and rising birth rates expanding ultrasound utilization globally	1.8%	Moderate	North America, Europe, Asia Pacific	High	Near Term
Expansion of portable point-of-care ultrasound in ambulatory and emergency care	1.5%	Moderate	Asia Pacific, North America, Europe	Medium	Mid Term

Regional Demand Dynamics

North America (Largest Region) vs Asia Pacific (Fastest-Growing Region)

North America held the largest share of the diagnostic ultrasound market at 36.5% in 2026, supported by advanced healthcare infrastructure, high utilization of diagnostic imaging, and broad adoption of technologically sophisticated ultrasound systems. Growing demand for non-invasive diagnostic procedures across obstetrics, cardiology, emergency care, and general imaging is strengthening utilization, while improvements in image quality, portability, and workflow integration are expanding clinical applications. Established reimbursement structures and continued investment in healthcare technology further contribute to the region's strong market position.

Asia Pacific is poised to experience the fastest growth in the diagnostic ultrasound market as healthcare infrastructure expands and access to diagnostic imaging improves across developing economies. Rising awareness of early disease detection, increasing healthcare expenditure, and growing demand for minimally invasive diagnostic procedures are encouraging greater adoption of ultrasound technologies. The expansion of hospitals and diagnostic centers, together with the increasing availability of portable and cost-efficient systems, is also helping extend ultrasound services to underserved and emerging healthcare markets.

No card data available for this language/report.

Segment Leadership and Growth Trends

 

Portability Segment Analysis: Trolley (Largest Segment) vs Compact/handheld (Fastest-Growing Segment)

The trolley portability segment accounted for a 65.47% share in 2026, making it the leading portability category. Its dominance is supported by its widespread use across hospitals and diagnostic imaging departments where advanced imaging capabilities, multiple transducer compatibility, and comprehensive examination features are essential. Trolley-based systems also provide greater functionality for complex clinical assessments, enabling healthcare professionals to perform a broad range of diagnostic procedures with high efficiency.

The compact/handheld portability segment is expected to witness the fastest growth in the diagnostic ultrasound market as healthcare providers increasingly adopt portable imaging solutions for point-of-care diagnostics and decentralized healthcare delivery. Their lightweight design, ease of transportation, and ability to deliver rapid bedside assessments make them well suited for emergency care, outpatient services, and remote clinical settings. Continuous improvements in portable imaging technology are expected to further support segment expansion.

Technology Segment Analysis: Doppler (Largest Segment) vs 3D and 4D (Fastest-Growing Segment)

The doppler technology segment held a 38.12% share in 2026, establishing it as the leading technology category. Its strong market position is driven by its ability to evaluate blood flow, vascular function, and cardiac performance, making it an essential diagnostic tool across cardiovascular, obstetric, and general imaging applications. The broad clinical utility of doppler imaging and its integration into routine diagnostic workflows continue to support its widespread adoption.

In the diagnostic ultrasound market, the 3D and 4D technology segment is anticipated to record the fastest growth due to increasing demand for advanced visualization capabilities that improve diagnostic confidence and clinical assessment. These technologies provide enhanced anatomical detail and real-time imaging, supporting more comprehensive evaluations across obstetrics, gynecology, cardiology, and other specialized medical fields. Ongoing innovation in imaging quality and workflow efficiency is expected to accelerate adoption.

End-use Segment Analysis: Hospitals (Largest Segment) vs Maternity Centers (Fastest-Growing Segment)

The hospitals segment accounted for a 54.38% share in 2026, making it the largest end-use category. Its leadership is supported by the availability of advanced diagnostic infrastructure, skilled healthcare professionals, and high patient volumes requiring ultrasound examinations across multiple medical specialties. Hospitals also perform a broad range of routine and complex imaging procedures, contributing to sustained demand for diagnostic ultrasound systems.

The maternity centers segment is projected to witness the fastest growth in the diagnostic ultrasound market as specialized maternal and fetal care services continue to expand. Increasing emphasis on prenatal monitoring, early fetal assessment, and comprehensive pregnancy care is driving greater adoption of advanced ultrasound technologies within dedicated maternity facilities. The continued focus on improving maternal healthcare services is expected to strengthen the growth outlook for this segment.

Report Segmentation
Segment	Sub-Segment	Largest Segment	Fastest Growing Segment
Portability	Trolley, Compact/handheld	Trolley	Compact/handheld
Technology	2D,3D and 4D, Doppler	Doppler	3D and 4D
End-use	Hospitals, Maternity Centers, Others	Hospitals	Maternity Centers
Application	General Imaging, Cardiology, OB/GYN, Others	General Imaging	Cardiology

Competitive Landscape and Market Positioning

Prominent players in the diagnostic ultrasound market:

1. GE HealthCare (United States)
2. Siemens Healthineers AG (Germany)
3. Koninklijke Philips N.V. (Netherlands)
4. Canon Medical Systems Corporation (Japan)
5. Samsung Medison Co., Ltd. (South Korea)
6. Fujifilm Holdings Corporation (Japan)
7. Mindray Medical International Limited (China)
8. Esaote S.p.A. (Italy)
9. Hologic, Inc. (United States)
10. Butterfly Network, Inc. (United States)

Clinical workflow expectations and expanding point-of-care applications are redefining competitive dynamics within the diagnostic ultrasound market. Manufacturers are placing greater emphasis on image quality supported by intelligent automation, simplified user interfaces, and compact system designs that broaden accessibility across healthcare settings with varying levels of clinical expertise. The pace of innovation increasingly reflects how effectively vendors combine software capabilities, connectivity, and workflow optimization with dependable imaging performance. Suppliers that can support seamless data integration, remote collaboration, and versatile application portfolios are strengthening their competitive position as purchasing decisions increasingly consider long-term operational value alongside diagnostic capability.

Industry Development/News

Company Name	Date	Key Development
Canon Medical Systems USA	Nov-25	Canon Medical Systems USA obtained FDA 510(k) clearance for technology upgrades within its Aplio i-series diagnostic ultrasound systems. The regulatory clearance covers advancements intended to improve imaging clarity and workflow optimization across clinical ultrasound environments.
Fujifilm	Oct-25	Fujifilm introduced its ARIETTA 850 FF ENDO upgrade for endoscopic ultrasound applications. The system integration incorporates attenuation measurement and 2D shear wave elastography to enhance technical functionality and diagnostic capabilities during ultrasound-guided endoscopic assessments.
Cobionix	Jul-25	Cobionix secured investment funding to accelerate the commercial deployment of its CODI collaborative medical robot platform. The capital infusion supports the scalability of AI-driven robotic applications that integrate medical imaging systems for healthcare facilities.
IMGT	Jun-25	IMGT advanced the technical development of its IMD10 ultrasound device designed for oncology care. The initiative focuses on the commercialization of specialized, ultrasound-based therapeutic technologies intended to alter treatment approaches in cancer therapy.
Samsung Electronics Co. Ltd.	May-24	Samsung Electronics Co. Ltd. acquired Sonio SAS, a developer of fetal ultrasound artificial intelligence software. The acquisition integrates advanced AI capabilities into Samsung's ultrasound architecture, optimizing clinical workflows and expanding the company's diagnostic imaging portfolio within prenatal healthcare segments.
Fujifilm India	Feb-24	Fujifilm India expanded its medical imaging footprint with the launch of the ALOKA ARIETTA 850 diagnostic ultrasound platform. The system introduces advanced imaging capabilities tailored for diagnostic and endoscopic workflows across the regional healthcare market.
Canon Medical Systems	Jan-24	Canon Medical Systems established a strategic business alliance with Olympus for endoscopic ultrasound systems. The collaboration integrates the respective technical expertise of both companies to co-develop and commercialize diagnostic imaging solutions optimized for endoscopic ultrasound procedures.
GE HealthCare	Feb-23	GE HealthCare signed an agreement to acquire Caption Health, Inc., a company specializing in artificial intelligence healthcare applications. This integration incorporates AI-driven software into GE's precision care portfolio, enabling broader clinical execution of diagnostic ultrasound scans and basic echocardiograms.